RNTX
Rein Therapeutics, Inc. Common Stock
RNTX
RNTX
16 hedge funds and large institutions have $1.59M invested in Rein Therapeutics, Inc. Common Stock in 2023 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 3 increasing their positions, 2 reducing their positions, and 2 closing their positions.
Holders
16
Holders Change
-1
Holders Change %
-5.88%
% of All Funds
0.26%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
1
Increased
3
Reduced
2
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
Top Sellers
1 |
1
UBS Group
Zurich,
Switzerland
|
$0 |
2 |
2
William Blair & Company
Chicago,
Illinois
|
$44.1K |
3 |
3
Vanguard Group
Malvern,
Pennsylvania
|
$60.7K |
4 |
IGWM
4
ICA Group Wealth Management
Denver,
Colorado
|
$0 |